Imanshahidi M et al. Berberine and barberry (Berberis vulgaris): A clinical review. Phytother Res. 2019;33(3):504-523. Neag MA et al. Berberine: botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders. Front Pharmacol. 2018;9:557. Dhamgaye S et al. Molecular mechanisms of action of herbal antifungal alkaloid berberine, in Candida albicans. PLoS ONE 2014;9(8):e104554. Jiang X et al. Berberine combined with triple therapy versus triple therapy for Helicobacter pylori eradication: a meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2018;2018:8716910. Hawrelak J. Giardiasis: pathophysiology and management. Altern Med Rev. 2003;8(2):129-42. Feng X et al. Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics. Theranostics. 2019;9(7):1923-1951. DiNicolantonio JJ et al. Astaxanthin plus berberine: a nutraceutical strategy for replicating the benefits of a metformin/fibrate regimen in metabolic syndrome. Open Heart. 2019;6:e000977. Zheng H et al. Antimicrobial natural product berberine is efficacious for the treatment of atrial fibrillation. Biomed Res Int. 2017;2017:3146791. Zeng XH et al. Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2003;92(2):173-176. Liu DQ et al. Berberine protects against ischemia-reperfusion injury: A review of evidence from animal models and clinical studies. Pharmacol Res. 2019;148:104385. Cicero AFG et al. Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Arch Med Sci. 2017;13(5):965-1005. Koppen LM et al. Efficacy of berberine alone and in combination for the treatment of hyperlipidemia: a systematic review. J Evid Based Complementary Altern Med. 2017;22(4):956-968. Zhu X et al. The potential mechanisms of berberine in the treatment of nonalcoholic fatty liver disease. Molecules. 2016;21(10). Li N et al. Berberine attenuates pro-inflammatory cytokine-induced tight junction disruption in an in vitro model of intestinal epithelial cell. Eur J Pharm Sci. 2010;40:1-8. Habtemariam S. Berberine and inflammatory bowel disease: a concise review. Pharmacol Res. 2016;113(A):592-599. Chen C et al. A randomized clinical trial of berberine hydrochloride in patients with diarrhea-predominant irritable bowel syndrome. Phytother Res. 2015;29(11):1822-7. Fan D et al. Combating neurodegenerative diseases with the plant alkaloid berberine: molecular mechanisms and therapeutic potential. Curr Neuropharmacol. 2019;17(6):563-579. Zou K et al. Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system. Acta Pharmacol Sin. 2017;38(2):157-167. An Y et al. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment. Clin Endocrinol (Oxf). 2014;80(3):425-31. Li G et al. Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy. Med Oncol. 2010;27:919-925. Rauf A et al. Berberine as a potential anticancer agent: a comprehensive review. Molecules. 2021;26(23):7368. Xu J et al. Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis. BMC Cancer. 2019;19:589. Zhang J et al. Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling. J Cell Mol Med. 2013;17(11):1484-93. Ye Y et al. Efficacy and safety of berberine alone for several metabolic disorders: a systematic review and meta-analysis of randomized clinical trials. Front Pharmacol. 2021;12:653887. Guo J et al. The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Oxid Med Cell Longev. 2021;2021:2074610. Shabani E et al. Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats. BMC Complement Med Ther. 2021;21(1):301. Mohammadian Haftcheshmeh S et al. Berberine as a promising natural compound for the treatment of periodontal disease: a focus on anti-inflammatory properties. J Cell Mol Med. 2021;25(24):11333-11337. Rui R et al. Effects of berberine on atherosclerosis. Front Pharmacol. 2021;12:764175.